Haris Mirza
استادیار · Cancer Immunology
Max Planck Institute of Molecular Cell Biology and Geneticsمعرفی
Dr. Haris Mirza is an Assistant Professor of Pathology at Yale School of Medicine with a multifaceted career as both a physician-scientist and academic researcher. His work bridges clinical pathology with laboratory investigation, focusing on the intersection of immunology and cancer biology. Dr. Mirza maintains multiple institutional affiliations that support his interdisciplinary approach to research.
Dr. Mirza's educational journey includes:
- MBBS from DOW Medical College (2006)
- PhD from National University of Singapore (2012)
- Postdoctoral Fellowship at Yale School of Medicine (2016)
- Residency at Yale School of Medicine (2020)
- GI & Liver Pathology Fellowship at Yale School of Medicine (2023)
His research primarily investigates the role of the immune system in colon cancer development, with particular emphasis on T cell biology and tumor microenvironment interactions. Dr. Mirza's laboratory work complements his clinical practice as a pathologist specializing in gastrointestinal and liver pathology, creating a powerful translational research framework. His publications demonstrate expertise across multiple domains including cancer immunology, infectious disease mechanisms, and molecular pathology.
Analysis of Dr. Mirza's publication record reveals a strategic evolution from early work on parasitic infections and dermatopathology toward his current focus on cancer immunology. His most recent publications (2021-2025) appear in high-impact journals including Nature, Cell, and PNAS, focusing on T cell immunity in cancer, humanized mouse models, and immune responses to viral infections.
Dr. Mirza has received significant recognition for his research:
- Career Development Award (K08) from National Cancer Institute (2023)
- James Hudson Brown – Alexander Brown Coxe Fellowship from Yale School of Medicine (2014)
As a physician-scientist, Dr. Mirza maintains an active clinical practice in gastrointestinal and liver pathology while leading a productive research program. His work is supported by multiple collaborations across Yale's research community, particularly with immunologists and cancer biologists. Dr. Mirza's dual expertise in clinical pathology and laboratory research positions him as a valuable mentor for students interested in translational medicine and cancer immunology.


